While Inflammatory Bowel Diseases has been around for more than 20 years, the partnership with Oxford University Press will help expand the journal’s reach as bowel disease research and treatment continues to advance. Oxford University Press is one of the world’s oldest and most prestigious university presses, with more than 500 years of publishing experience.
The journal features the latest findings on both basic and treatment-development-related science on inflammatory bowel diseases. Its main mission is to increase the knowledge of doctors and researchers working on IBD and related disorders.
Each issue features research findings on IBD diagnosis, treatment and management, as well as an overview of the processes involved in the disease. Children’s bowel disease is one of the most important topics addressed in some issues.
The editors in charge of the journal, Bret Lashner and Fabio Cominelli, said in a press release that they will “work with our outstanding editors and new editorial staff from Oxford University Press to publish innovative clinical and basic research, timely reviews and meta-analyses, future directions of clinical care, and editors’ commentaries. Our goal is to further develop the journal to be a cover-to-cover ‘must read’ for all those interested in inflammatory bowel diseases.”
“For over 20 years, Inflammatory Bowel Diseases has provided the IBD community with high-quality articles about the most groundbreaking advances in IBD research and clinical care,” said Caren Heller, the foundation’s chief scientific officer. “The foundation is excited to partner with Oxford University Press to expand the journal’s presence and reach as the field continues to advance towards better treatments and cures for Crohn’s and colitis.”
“Our entire global journals team is extremely enthusiastic about partnering with the Foundation for publication of their highly regarded journal Inflammatory Bowel Diseases,” said Alison Denby, Oxford University Press’s journals publishing director. “We are eager to expand the journal’s readership to a more global audience, as well as to help further its impact as an invaluable resource to the clinician, research, and patient communities it serves.”
Click here to access the latest issue of Inflammatory Bowel Diseases.